Factors associated with prognosis in COPD: influence of body composition and systemic corticosteroid use on morbidity and mortality

Abstract

References

l. Wilson DO , Rogers RM , Wright EC , Anthonisen NR . Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial . Am Rev Respir Dis 1989; 139: 1435-1438 .

2. Landbo C , Prescott E , Lange P , Vestbo J , Almdal TP Prognostic value of nutritional status in chronic obstructive pulmonary disease . Am J Respir Crit Care Med 1999; 160: 1856-1861 .

3. Schols AMWJ , Slangen J , Volovics L , Wouters EFM . Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease . Am J Respir Crit Care Med 1998; 157: 1791-1797 .

4. Gray Donald K , Gibbons L , Shapiro SH , Macklem PT , Martin JG . Nutritional status and mortality in chronic obstructive pulmonary disease . Am J Respir Crit Care Med 1996; 153: 961-966 .

5. Ringbaek TJ , Viskum K , Lange P . BMI and oral glucocorticoids as predictors of prognosis in COPD patients on LTOT . Chronic Respir Dis, 2004; 1: 71-78 .

6. Chailleux E , Laaban JP , Veale D . Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory . Chest 2003; 123: 1460-1466 .

7. Engelen MPKJ , Schols AMWJ , Baken WC , Wesseling GJ , Wouters EFM . Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD . Eur Respir J 1994; 7: 1793-1797 .

8. Schols AMWJ , Soeters PB , Dingemans AM , Mostert R , Frantzen PJ , Wouters EFM . Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation . Am Rev Respir Dis 1993; 147: 1151-1156 .

9. Engelen M , Schols A , Lamers RJS , Wouters EFM . Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease . Clin Nutr 1999; 18: 275-280 .

10.

10. Mostert R , Goris A , Weling-Scheepers C , Wouters EF , Schols AM . Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease . Respir Med 2000; 94: 859-867 .

11.

11. Baarends EM , Schols AM , Mostert R , Wouters EF Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease . Eur Respir J 1997; 10: 2807-2813 .

12.

12. Marquis K , Debigare R , Lacasse Y et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease . Am J Respir Crit Care Med 2002; 166: 809-813 .

13.

13. Pouw EM , Ten Velde GP , Croonen BH , Kester AD , Schols AM , Wouters EE Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss . Clin Nutr 2000; 19: 95-99 .

14.

14. Decramer M , Gosselink R , Troosters T , Verschueren M , Evers G . Muscle weakness is related to utilization of health care resources in COPD patients . Eur Respir J 1997; 10: 417-423 .

15.

15. Creutzberg EC , Wouters EFM , Mostert R , Weling-Scheepers CAPM , Schols AMWJ . Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease . Nutrition 2003; 19: 120-127 .

16.

16. Prescott E , Almdal T , Mikkelsen KL , Tofteng CL , Vestbo J , Lange P . Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study . Eur Respir J 2002; 20: 539-544 .

17.

17. Celli BR , Cote CG , Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease . N Engl J Med 2004; 350: 1005-1012 .

18.

18. Hajiro T , Nishimura K , Tsukino M , Ikeda A , Oga T , Izumi T . A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD . Chest 1999; 116: 1632-1637 .

19.

19. Nishimura K , Izumi T , Tsukino M , Oga T . Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD(*) . Chest 2002; 121: 1434-1440 .

20.

20. Oga T , Nishimura K , Tsukino M , Sato S , Hajiro T . Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status . Am J Respir Crit Care Med 2003; 167: 544-549 .

21.

21. Schols AM , Wesseling G , Kester AD et al. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids . Eur Respir J 2001; 17: 337-342 .

22.

22. Sin DD , Tu JV Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease . Am J Respir Crit Care Med 2001; 164: 580-584 .

23.

23. Groenewegen KH , Schols AM , Wouters EF . Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD . Chest 2003; 124: 459-467 .

24.

24. Strom K . Oral corticosteroid treatment during long-term oxygen therapy in chronic obstructive pulmonary disease: a risk factor for hospitalization and mortality in women . Respir Med 1998; 92: 50-56 .

25.

25. McEvoy CE , Niewoehner DE . Adverse effects of corticosteroid therapy for COPD. A critical review [see comments] . Chest 1997; 111: 732-743 .

26.

26. Pauwels RA , Buist AS , Calverley PM , Jenkins CR , Hurd SS . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Nhlbi/who global initiative for chronic obstructive lung disease (gold) workshop summary . Am J Respir Crit Care Med 2001; 163: 1256-1276 .

27.

27. Creutzberg EC , Wouters EFM , Mostert R , Pluymers RJ , Schols AMWJ . A role for anabolic steroids in the rehabilitation of patients with COPD?: a double-blind, placebo-controlled, randomized trial . Chest 2003; 124: 1733-1742 .